In a context strongly marked by the pandemic, the Group’s EBITDA margin remained robust at 15.0%, supported by the resilience of its Specialty Materials  and by the rebound in volumes in the fourth quarter (+5% vs Q4’19).
Arkema is well positioned to take advantage of the recovery in 2021 and beyond, thanks to the benefits of its strong balance sheet and its focus on sustainable and high performance Specialty Materials.
Arkema will invest to further increase its fluoropolymer production capacities in Changshu by 35% in 2022. Simultaneously, we celebrate the first ten years of successful PVDF production at our Changshu site in China.
Bostik reinforces its presence in the fast-growing Brazilian construction adhesives market with the planned acquisition of Poliplas, a leader in hybrid-technology sealants and adhesives. This project is in line with Arkema’s targeted growth strategy in adhesives and in high-growth regions.
The founding members of the Pragati project for sustainable castor crop – Arkema, BASF, Jayant Agro-Organics along with implementation partner Solidaridad – recently finalized and published the final audited and certified results of the fourth year of their program.
Arkema announces an investment in CMC (Crackless Monomer Company), a joint venture between Bostik and Taiwanese company Cartell Chemical Co, a leading supplier of cyanoacrylate solutions, to accelerate the development and production of high value-added engineering adhesives.
Arkema announces the acquisition of Colorado Photopolymer Solutions, a company based in Boulder, Colorado, U.S.A., with strong technical expertise in photopolymer formulation for the fast-growing 3D printing market, with applications in the medical, composites, construction and consumer goods sectors.
Arkema starts up its 50% capacity increase of Kynar® fluoropolymer for the lithium-ion battery business at its Changshu plant in China in December 2020, with the first commercial supplies for January 2021.
Arkema leads the Series B investment in Adaptive3D, an innovative company and premium additive manufacturing photopolymer resin supplier. This investment complements our expertise in UV liquid resin material design and our commitment to accelerate 3D printing manufacturing technology development.
Today, Arkema successfully placed its first ever Green Bond fully dedicated to the financing of its new world-scale plant in Singapore to manufacture 100% bio-based Rilsan® polyamide 11. For a total amount of €300 million, this Green Bond has a maturity of 6 years and an annual coupon of 0.125%. The offering was more than 10 times oversubscribed.
Bostik reinforces its range of flooring products with the planned acquisition of Ideal Work, an Italian company specialized in high-added value decorative flooring technologies. This project is in line with Arkema’s targeted growth strategy in adhesives, based on cutting-edge technologies which perfectly complete Bostik’s existing offering for the construction market.
Partner of the ZEBRA (Zero wastE Blade ReseArch) project driven by IRT-Jules Verne, which brings together leading players and technical centres around an ambitious project addressing the design and production of the first 100% recyclable wind turbine blade, Arkema is strengthening its position as a key player in the thermoplastic composite market with its Elium® resin. This resin is perfectly in line with the circular economy approach that the Group has initiated for both its operations and its products.
Arkema announces the start-up of a new world-scale industrial adhesives plant in Japan. Those new capacities will enable Bostik to serve its Japanese customers in the continuously growing markets of diapers, hygiene, packaging, labelling, transportation and electronics. This investment is in line with Bostik’s growth and geographical expansion strategy.
Arkema announces the proposed acquisition of Fixatti, a company specialized in high-performance thermobonding adhesive powders. This acquisition will enable Bostik to strengthen its global offering of hotmelt adhesive solutions for niche industrial applications in the construction, technical coating, battery, automotive, and textile printing markets. This project is part of Bostik's targeted growth strategy in high value-added technologies, and is perfectly in line with the Group's roadmap to become a pure Specialty Materials player by 2024 centered around Adhesive Solutions, Advanced Materials, and Coating Solutions.
Arkema announces an innovative and long-term partnership with Nutrien Ltd, the largest integrated agricultural company in the world, for the supply of anhydrous hydrogen fluoride to Arkema’s Calvert City (KY) site. This project has many advantages as it secures a competitive access to anhydrous hydrogen fluoride, the main raw material for fluorine chemistry, it supports the growth of fluoropolymers in the attractive segments of water treatment, electronics and batteries, and it offers greater environmental protection than more traditional production processes.
The combined annual general meeting of Arkema’s shareholders was held on 19 May 2020, at the Company’s headquarters in Colombes, France, under the chairmanship of Thierry Le Hénaff, Chairman and Chief Executive Officer.
The Group’s results are in line with expectations, in a first quarter marked by the coronavirus outbreak in Asia and its spread to Europe in March. Stripping out the coronavirus impact, the Group’s performance, in a less favorable economic environment than in 2019, was supported by the resilience of Specialty Materials and, in particular, strong growth of the Adhesive Solutions segment. Moreover, the balance sheet and liquidity levels remain very solid.
At a Strategy Update meeting on April 2, Arkema presents its ambition to become a world leader in Specialty Materials realigned around three coherent businesses with attractive growth prospects: Adhesive Solutions, Advanced Materials, and Coating Solutions. The Group unveils its roadmap and its objectives for 2024 at this event. In the context of Covid-19, Arkema also provides an update on the management and the consequences of this unprecedented health crisis.
In response to the COVID-19 epidemic and the health situation, Arkema has decided to repurpose a production line in order to manufacture, starting today, 20 tons of alcohol-based solution per week to be distributed free of charge and as a matter of urgency to hospitals in France.
Arkema is carrying out a capital increase reserved for the current and former employees of the Arkema Group in thirty countries, including France (representing 98 % of the employees of the Group). The subscription period will take place from March 6, 2020 to March 19, 2020 (inclusive).